1. Home
  2. EVV vs RAPP Comparison

EVV vs RAPP Comparison

Compare EVV & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVV
  • RAPP
  • Stock Information
  • Founded
  • EVV 2003
  • RAPP 2022
  • Country
  • EVV United States
  • RAPP United States
  • Employees
  • EVV N/A
  • RAPP N/A
  • Industry
  • EVV Finance/Investors Services
  • RAPP
  • Sector
  • EVV Finance
  • RAPP
  • Exchange
  • EVV Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • EVV 1.2B
  • RAPP 1.2B
  • IPO Year
  • EVV N/A
  • RAPP 2024
  • Fundamental
  • Price
  • EVV $9.93
  • RAPP $26.66
  • Analyst Decision
  • EVV
  • RAPP Strong Buy
  • Analyst Count
  • EVV 0
  • RAPP 3
  • Target Price
  • EVV N/A
  • RAPP $35.33
  • AVG Volume (30 Days)
  • EVV 323.7K
  • RAPP 504.2K
  • Earning Date
  • EVV 01-01-0001
  • RAPP 11-06-2025
  • Dividend Yield
  • EVV 9.66%
  • RAPP N/A
  • EPS Growth
  • EVV N/A
  • RAPP N/A
  • EPS
  • EVV N/A
  • RAPP N/A
  • Revenue
  • EVV N/A
  • RAPP N/A
  • Revenue This Year
  • EVV N/A
  • RAPP N/A
  • Revenue Next Year
  • EVV N/A
  • RAPP N/A
  • P/E Ratio
  • EVV N/A
  • RAPP N/A
  • Revenue Growth
  • EVV N/A
  • RAPP N/A
  • 52 Week Low
  • EVV $8.52
  • RAPP $6.43
  • 52 Week High
  • EVV $10.07
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • EVV 36.43
  • RAPP 55.20
  • Support Level
  • EVV $9.85
  • RAPP $24.25
  • Resistance Level
  • EVV $10.23
  • RAPP $27.03
  • Average True Range (ATR)
  • EVV 0.10
  • RAPP 1.61
  • MACD
  • EVV -0.02
  • RAPP -0.46
  • Stochastic Oscillator
  • EVV 18.75
  • RAPP 45.36

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: